137 related articles for article (PubMed ID: 19670700)
1. Immunohistochemical pattern of protein P21, cyclin D1 and cyclin E in endometrial hyperplasia.
Brucka A; Bartczak P; Ratyńska M; Sporny S
Pol J Pathol; 2009; 60(1):19-25. PubMed ID: 19670700
[TBL] [Abstract][Full Text] [Related]
2. Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables.
Ozuysal S; Oztürk H; Bilgin T; Filiz G
Arch Gynecol Obstet; 2005 Feb; 271(2):123-6. PubMed ID: 14740230
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of retinoblastoma protein expression in endometrial hyperplasia.
Brucka A; Bartczak P; Sporny S
Pol J Pathol; 2007; 58(3):173-82. PubMed ID: 18074862
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of cell cycle-related molecules in gastric carcinoma: prognostic significance, correlation with clinicopathological parameters, proliferation and apoptosis.
Lee KH; Lee HE; Cho SJ; Cho YJ; Lee HS; Kim JH; Nam SY; Chang MS; Kim WH; Lee BL
Pathobiology; 2008; 75(6):364-72. PubMed ID: 19096232
[TBL] [Abstract][Full Text] [Related]
5. Progressive derailment of cell cycle regulators in endometrial carcinogenesis.
Horrée N; van Diest PJ; van der Groep P; Sie-Go DM; Heintz AP
J Clin Pathol; 2008 Jan; 61(1):36-42. PubMed ID: 17483252
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 and Ki-67 expression in normal, hyperplastic and neoplastic endometrium.
Shevra CR; Ghosh A; Kumar M
J Postgrad Med; 2015; 61(1):15-20. PubMed ID: 25511212
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical study of the expression of receptors to steroid hormones in endometrial hyperplastic processes].
Lysenko ON; Ashkhab MKh; Strizhova NV; Babichenko II
Arkh Patol; 2004; 66(2):7-10. PubMed ID: 15154374
[TBL] [Abstract][Full Text] [Related]
8. Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas.
Nikaido T; Li SF; Shiozawa T; Fujii S
Cancer; 1996 Sep; 78(6):1248-53. PubMed ID: 8826947
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but not with prognosis.
Nishimura Y; Watanabe J; Jobo T; Kato N; Fujisawa T; Kamata Y; Kuramoto H
Anticancer Res; 2004; 24(4):2185-91. PubMed ID: 15330159
[TBL] [Abstract][Full Text] [Related]
10. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
11. Expression of cyclin D1 in endometrial hyperplasia and endometrial carcinoma.
Choudhury M; Bansal S
Indian J Pathol Microbiol; 2007 Oct; 50(4):708-10. PubMed ID: 18306533
[TBL] [Abstract][Full Text] [Related]
12. Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E.
Kashima H; Shiozawa T; Miyamoto T; Suzuki A; Uchikawa J; Kurai M; Konishi I
Endocr Relat Cancer; 2009 Mar; 16(1):113-22. PubMed ID: 18852162
[TBL] [Abstract][Full Text] [Related]
13. Estrogen-induced proliferation of normal endometrial glandular cells is initiated by transcriptional activation of cyclin D1 via binding of c-Jun to an AP-1 sequence.
Shiozawa T; Miyamoto T; Kashima H; Nakayama K; Nikaido T; Konishi I
Oncogene; 2004 Nov; 23(53):8603-10. PubMed ID: 15467760
[TBL] [Abstract][Full Text] [Related]
14. Dienogest, a synthetic progestin, inhibits the proliferation of immortalized human endometrial epithelial cells with suppression of cyclin D1 gene expression.
Shimizu Y; Takeuchi T; Mita S; Mizuguchi K; Kiyono T; Inoue M; Kyo S
Mol Hum Reprod; 2009 Oct; 15(10):693-701. PubMed ID: 19502247
[TBL] [Abstract][Full Text] [Related]
15. Expression of cell-cycle regulatory proteins cyclin D1, cyclin E, and their inhibitor p21 WAF1/CIP1 in gastric cancer.
Müller W; Noguchi T; Wirtz HC; Hommel G; Gabbert HE
J Pathol; 1999 Oct; 189(2):186-93. PubMed ID: 10547573
[TBL] [Abstract][Full Text] [Related]
16. A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes.
Tenderenda M
J Exp Clin Cancer Res; 2005 Sep; 24(3):405-14. PubMed ID: 16270527
[TBL] [Abstract][Full Text] [Related]
17. Expression of cyclin A, cyclin E and p27 in normal, hyperplastic and frankly malignant endometrial samples.
Gezginc ST; Celik C; Dogan NU; Toy H; Tazegul A; Colakoglu MC
J Obstet Gynaecol; 2013 Jul; 33(5):508-11. PubMed ID: 23815208
[TBL] [Abstract][Full Text] [Related]
18. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
Catalano S; Giordano C; Rizza P; Gu G; Barone I; Bonofiglio D; Giordano F; Malivindi R; Gaccione D; Lanzino M; De Amicis F; Andò S
J Cell Physiol; 2009 Mar; 218(3):490-500. PubMed ID: 18988190
[TBL] [Abstract][Full Text] [Related]
19. Immunoexpression of Cyclin D1 and PTEN in Various Endometrial Pathologies.
Shawana S; Kehar SI; Masood S; Aamir I
J Coll Physicians Surg Pak; 2016 Apr; 26(4):277-82. PubMed ID: 27097697
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
